Nektar Therapeutics | NKTR - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Agios Pharmaceuticals USD 89.13M 3.58M 2025-12
ALKERMES USD 388.57M 227.88M 2025-12
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 9.13B 316M 2025-12
Baxter International USD 1.97B 240M 2025-12
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
Biogen USD 3.01B 854.3M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Cara Therapeutics USD 21.42M 770K 2025-09
Cipla INR 7.96B 39.9M 2025-09
Dr.Reddys Laboratories INR 18.66B 8.75B 2025-12
Eisai JPY 301.65B 16.27B 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Exelixis USD 482.49M 106.19M 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Grifols EUR 979.78M 334.84M 2024-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Incyte USD 3.58B 650.78M 2025-12
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
Merck USD 18.17B 10.16B 2025-09
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Takeda JPY 654.94B 26.55B 2025-12
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Xencor USD 54.07M 25.78M 2025-12